Home ROVI will present positive results of Risperidone ISM® and Bemiparin at the 12th EACPT Congress

ROVI will present positive results of Risperidone ISM® and Bemiparin at the 12th EACPT Congress

Find out more …

General Information
of the Company
Financial and
Economic Information
Corporate Governance
Information for Investors
Contact
Read time: 0 mins
ROVI will present positive results of Risperidone ISM® and Bemiparin at the 12th EACPT Congress
https://rovi.es/sites/default/files/ROVI%20will%20present%20positive%20results%20of%20Risperidone%20ISM%C2%AE%20and%20Bemiparin%20at%20the%2012th%20EACPT%20Congress%2826-06-2015%29.pdf
Year: 
2015